Page Range | 14002-14002 | |
FR Document | 2017-05247 |
[Federal Register Volume 82, Number 50 (Thursday, March 16, 2017)] [Notices] [Page 14002] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-05247] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-N-2016-4198] Public Meeting on Patient-Focused Drug Development for Sarcopenia; Request for Comments; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration is correcting a notice entitled ``Public Meeting on Patient-Focused Drug Development for Sarcopenia'' that appeared in the Federal Register of December 14, 2016 (81 FR 90361). The document announced a public meeting and an opportunity for public comment on Patient-Focused Drug Development for Sarcopenia. The location of the meeting has changed and this document provides the updated meeting location. FOR FURTHER INFORMATION CONTACT: Meghana Chalasani, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 1146, Silver Spring, MD 20993-0002, 240- 402-6525, FAX: 301-847-8443, [email protected]. In the Federal Register of Wednesday, December 14, 2016, in FR Doc. 2016-29998, the following correction is made: 1. On page 90361, in the second column, in the first sentence of the ADDRESSES section, ``FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room, (Rm. 1503), Silver Spring, MD 20993-0002.'' is corrected to read ``Tommy Douglas Conference Center, 10000 New Hampshire Ave., Silver Spring, MD 20903.'' Dated: March 13, 2017. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2017-05247 Filed 3-15-17; 8:45 am] BILLING CODE 4164-01-P
Category | Regulatory Information | |
Collection | Federal Register | |
sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
Publisher | Office of the Federal Register, National Archives and Records Administration | |
Section | Notices | |
Action | Notice; correction. | |
Contact | Meghana Chalasani, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 1146, Silver Spring, MD 20993-0002, 240- 402-6525, FAX: 301-847-8443, [email protected] | |
FR Citation | 82 FR 14002 |